Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Rare Diseases

Last data update: Mar 24, 2023. (Total: 58922 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 45 Records)

Next

Query Trace: Cystic Fibrosis[original query]>>Evidence Synthesis [Product Type]
Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia.
Louise J Geneen et al. The Cochrane database of systematic reviews 2023 3(3) CD012349
Economic evaluation of population-based expanded reproductive carrier screening for genetic diseases in Australia.
Deborah Schofield et al. Genetics in medicine : official journal of the American College of Medical Genetics 2023 100813
Needs of people with rare diseases that can be supported by electronic resources: a scoping review.
Long Janet C et al. BMJ open 2022 12(9) e060394
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
Lo David Kh et al. The Cochrane database of systematic reviews 2022 12CD009650
Laser therapy for retinopathy in sickle cell disease.
Myint Kay Thi et al. The Cochrane database of systematic reviews 2022 12(12) CD010790
Newly Discovered Cutting-Edge Triple Combination Cystic Fibrosis Therapy: A Systematic Review.
Dawood Sarah N et al. Cureus 2022 14(9) e29359
Inhaled nitric oxide for treating pain crises in people with sickle cell disease.
Aboursheid Tarek et al. The Cochrane database of systematic reviews 2022 7CD011808
Implementation of prognostic machine learning algorithms in paediatric chronic respiratory conditions: a scoping review.
Filipow Nicole et al. BMJ open respiratory research 2022 9(1)
Receiving results of uncertain clinical relevance from population genetic screening: systematic review & meta-synthesis of qualitative research.
Johnson Faye et al. European journal of human genetics : EJHG 2022
Maternal and foetal outcomes following natural vaginal versus caesarean section (c-section) delivery in women with bleeding disorders and carriers.
Karanth Laxminarayan et al. The Cochrane database of systematic reviews 2021 12CD011059
The prevalence of CFTR mutations in patients with chronic rhinosinusitis: A systematic review and meta-analysis.
Yong Michael et al. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 2021
Current updates and future perspectives in the evaluation of azoospermia: A systematic review.
Punjani Nahid et al. Arab journal of urology 2021 19(3) 206-214
Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI.
Brunelli Marcela Junqueira et al. The Cochrane database of systematic reviews 2021 9CD009806
Rituximab for eradicating inhibitors in people with acquired haemophilia A.
Remmington Tracey et al. The Cochrane database of systematic reviews 2021 8CD011907
Cascade health service use in family members following genetic testing in children: a scoping literature review.
Cernat Alexandra et al. European journal of human genetics : EJHG 2021
The Cost-effectiveness of Genotyping versus Sequencing for Prenatal Cystic Fibrosis Carrier Screening.
Avram Carmen M et al. Prenatal diagnosis 2021
Systematic Identification of Familial Hypercholesterolaemia in Primary Care-A Systematic Review.
Silva Luisa et al. Journal of personalized medicine 2021 11(4)
Cost-Effectiveness of Ivacaftor Therapy for Treatment of Cystic Fibrosis Patients With the G551D Gating Mutation.
Wherry Kael et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2020 Oct 23(10) 1332-1339
A systematic review of the clinical and genetic characteristics of Chinese patients with cystic fibrosis.
Shi Ruihe et al. Pediatric pulmonology 2020 Jul
Cost-effectiveness of the CFTR gene-sequencing test for asymptomatic carriers in the Colombian population
Andrade Ernesto et al. Biomedica : revista del Instituto Nacional de Salud 2020 40(2) 283-295
Spectrum of mutations of cystic fibrosis in the 22 Arab countries: A systematic review.
Al-Sadeq Duaa et al. Respirology (Carlton, Vic.) 2019 24(2) 127-136
Prenatal genetic testing for cystic fibrosis: a systematic review of clinical effectiveness and an ethics review.
Kessels Sharon J M et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Aug
Interventions for treating neuropathic pain in people with sickle cell disease.
Asnani Monika R et al. The Cochrane database of systematic reviews 2019 Jul 7CD012943
A model-based economic evaluation of four newborn screening strategies for cystic fibrosis in Flanders, Belgium.
Schmidt Masja et al. Acta clinica Belgica 2019 Apr 1-9
Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis.
Zhang Lei et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Feb
Health economic modelling in Cystic Fibrosis: A systematic review.
Mohindru Bishal et al. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2019 Feb
Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen.
Beauchamp Kyle A, et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 2 0.
Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
Thaker Vidhu et al. The Cochrane database of systematic reviews 2018 Dec 12CD008901
Gene therapy for sickle cell disease.
Olowoyeye Abiola et al. The Cochrane database of systematic reviews 2018 Nov 11CD007652
The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience.
Grosse Scott D et al. The Milbank quarterly 2016 94(2) 366-91
TOP